| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 04/21/2011 | CA2775959A1 Dual variable domain immunoglobulins and uses thereof |
| 04/21/2011 | CA2772995A1 Fused thiazolo and oxazolo pyrimidinones |
| 04/20/2011 | EP2311945A1 Bispecific antibodies substituting for functional proteins |
| 04/20/2011 | EP2311938A1 Method and apparatus for maintenance and expansion of hemopoietic stem cells and/or progenitor cells |
| 04/20/2011 | EP2311872A1 Albumin fusion proteins |
| 04/20/2011 | EP2311864A1 Recombinant protein-s composition |
| 04/20/2011 | EP2311852A1 Anti-infarction molecules |
| 04/20/2011 | EP2311847A1 Composition containing stable vitamin B6 derivative |
| 04/20/2011 | EP2311818A1 Combination of a 5-phenylthiazole compound as PI3 kinase inhibitor with an antiinflammatory, bronchodilatory or antihistamine drug |
| 04/20/2011 | EP2311810A1 Amidine derivative |
| 04/20/2011 | EP2311806A2 Dihydropyridine-, pyridine-, benzopyranone- and triazoloquinazoline derivatives, their preparation and their use as adenosine receptor antagonists |
| 04/20/2011 | EP2311432A1 Prevention and reduction of blood loss |
| 04/20/2011 | EP2310405A1 Peptide inhibitors of cd40l signaling and uses therefor |
| 04/20/2011 | EP2310366A2 Novel triazolo(4,3-a)pyridine derivatives, process for the preparation thereof, use thereof as medicaments, pharmaceutical compositions and novel use, in particular as met inhibitors |
| 04/20/2011 | EP2310054A2 Aptamer inhibition of thrombus formation |
| 04/20/2011 | EP2310043A1 Von willebrand factor or factor viii and von willebrand factor for the treatment of coagulopathy induced by inhibitors of thrombocytes |
| 04/20/2011 | EP2227466B1 Heteroaryl-substituted piperidines |
| 04/20/2011 | CN1839866B Medicinal composition containing breviscapine |
| 04/20/2011 | CN1824647B Crystal of (+-)2-(dimethylamino)-1-{[o-(m-methoxyphenethyl)phenoxy]methyl}ethyl hydrogen succinate hydrochloride |
| 04/20/2011 | CN1730475B Aromatic amine ketene compounds, its synthesis method, pharmaceutical composition containing same and uses |
| 04/20/2011 | CN1701117B Antibody against enzyme specifically cleaving VON WILLEBRAND factor and assay system using the same |
| 04/20/2011 | CN102026996A Pyridazine derivatives as factor XIA inhibitors |
| 04/20/2011 | CN102026995A 5,6-disubstituted oxindole-derivatives and use thereof for treating vasopressine-dependent diseases |
| 04/20/2011 | CN102026961A Amide compound |
| 04/20/2011 | CN102026654A Oxygen-transferring blood substitute and a pharmaceutical composition (variants) |
| 04/20/2011 | CN102026652A Thrombin inhibitor |
| 04/20/2011 | CN102021160A Snake venom serine protease and coding gene and application thereof |
| 04/20/2011 | CN102020521A Preparation mode and application of deuterium substituted Chinese herbal monomer |
| 04/20/2011 | CN102018910A Chinese medicinal preparation for treating septicemia |
| 04/20/2011 | CN102018880A Traditional Chinese medicine preparation for treating gestational edema |
| 04/20/2011 | CN102018877A Traditional Chinese medicine for promoting psychological and physiological wounds to heal |
| 04/20/2011 | CN102018842A Drug for treating aplastic anemia |
| 04/20/2011 | CN102018839A Medicinal wine for dissolving thrombus and prolonging life |
| 04/20/2011 | CN102018826A Traditional Chinese medicine for treating aplastic anemia |
| 04/20/2011 | CN102018816A Traditional Chinese medicine for treating anaphylactoid purpura |
| 04/20/2011 | CN102018791A Drug for treating allergic purpura |
| 04/20/2011 | CN102018736A Natural indigo decoction piece and preparation method thereof |
| 04/20/2011 | CN102018732A Medicinal composition consisting of chondroitin sulfate and/or medicinal salt thereof and ginkgo leaf extract |
| 04/20/2011 | CN102018724A Preparation method of medical artificial cerebrospinal fluid and application thereof |
| 04/20/2011 | CN102018718A Application of Xanthoceraside compound |
| 04/20/2011 | CN102018715A Immunomodulation and effect on cell processes relating to serotonin family receptors and the blood-brain barrier |
| 04/20/2011 | CN102018691A Medicament for treating thrombotic cardiovascular and cerebrovascular diseases and application thereof |
| 04/20/2011 | CN102018677A Roxatidine acetate hydrochloride used for injection and preparation method thereof |
| 04/20/2011 | CN102018675A Carbazochrome sodium sulfonate freeze-dried powder injection and preparation method thereof |
| 04/20/2011 | CN101623437B Pulse-activating preparation for injection and preparation method thereof |
| 04/20/2011 | CN101584670B Decitabine freeze-dried powder injection |
| 04/20/2011 | CN101407743B Method for extracting and separating curcuma oil |
| 04/20/2011 | CN101390856B Solid preparation of clopidogrel and preparation method thereof |
| 04/20/2011 | CN101318995B Substituted tetrahydro-isoquinoline isoquinolinium compound, preparation method and application thereof |
| 04/20/2011 | CN101314769B Staphylokinase and expression vector thereof |
| 04/20/2011 | CN101254267B Medicament for curing organic diseases of cervix inflammation, uterine hypertrophy and the like |
| 04/20/2011 | CN101240027B Conjugate constructed from normal nonyl and RGD peptide, and its synthesis and application in medicine |
| 04/20/2011 | CN101200466B Heterocyclic compounds having antithrombotic activity, preparation method and uses thereof |
| 04/20/2011 | CN101181476B External application medicine for curing podosoma phlebothrombosis and phlebitis as well as preparation method |
| 04/20/2011 | CN101112358B Staphylokinase intramuscular injection and method for preparing the same |
| 04/20/2011 | CN101045089B Traditional Chinese medicine with functions of tonifying-qi, supporting-Yang, tonifying-heart and clearing-damp, and its quality control method |
| 04/19/2011 | US7928255 Intermediates for the preparation of lipoxin A4 analogs |
| 04/19/2011 | US7928199 Stabilized proteins with engineered disulfide bonds |
| 04/19/2011 | US7928130 Isoxazoline compounds having MIF antagonist activity |
| 04/19/2011 | US7928125 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 04/19/2011 | US7928124 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 04/19/2011 | US7928119 Use of EP4 receptor ligands in the treatment of IL-6 involved diseases |
| 04/19/2011 | US7928066 Recombinant platelet collagen receptor glycoprotein vi and its pharmaceutical use |
| 04/19/2011 | US7927821 Methods of screening for compounds which bind G protein-coupled receptors |
| 04/19/2011 | US7927624 Hydrophilic/lipophilic polymeric matrix dosage formulation |
| 04/19/2011 | US7927622 Methods of transnasal transport/immunization with highly adaptable carriers |
| 04/19/2011 | US7927592 Method of inhibiting complement activation |
| 04/19/2011 | US7927365 Methods and apparatus for stenting comprising enhanced embolic protection coupled with improved protections against restenosis and thrombus formation |
| 04/19/2011 | US7927364 Methods and apparatus for stenting comprising enhanced embolic protection coupled with improved protections against restenosis and thrombus formation |
| 04/19/2011 | CA2628963C Benzene derivative or salt thereof |
| 04/19/2011 | CA2476012C Substituted pyridinones as modulators of p38 map kinase |
| 04/19/2011 | CA2474674C Solid preparation containing single crystal form |
| 04/19/2011 | CA2440557C Combinations of heparin cofactor ii agonist and platelet iib/iiia antagonist, and uses thereof |
| 04/19/2011 | CA2385659C Novel antiarrhythmic peptides |
| 04/14/2011 | WO2011044452A2 Methods and compositions for amelioration of autoimmune disease using fusion proteins of anti-dendritic cell receptor antibody to peptide sequences |
| 04/14/2011 | WO2011043480A1 Homocysteine synthase inhibitor |
| 04/14/2011 | WO2011043456A1 Halogenated alkylsulfonamide derivative |
| 04/14/2011 | WO2011043453A1 Activator for peroxisome proliferator activated receptor |
| 04/14/2011 | WO2011020866A3 Albumin fused coagulation factors for non-intravenous administration in the therapy and prophylactic treatment of bleeding disorders |
| 04/14/2011 | WO2010137855A3 Multi-layer tablet comprising effervescent layer |
| 04/14/2011 | US20110086904 GENERATION OF HYPERSTABLE mRNAs |
| 04/14/2011 | US20110086851 Substituted quinazolines and their uses for myeoloprolific and thrombotic diseases |
| 04/14/2011 | US20110086846 Azaindazole Compounds As CCR1 Receptor Antagonists |
| 04/14/2011 | US20110086826 Liposomal camptothecins and uses thereof |
| 04/14/2011 | US20110086801 Prevention and reduction of blood loss |
| 04/14/2011 | US20110086798 Erythropoietin compositions |
| 04/14/2011 | US20110086119 Preparation for the relief of disease |
| 04/14/2011 | US20110086069 Pharmaceutical formulations of nitrite and uses thereof |
| 04/14/2011 | US20110086050 Glycoprotein compositions |
| 04/14/2011 | US20110086040 Method of treating hemolytic disease |
| 04/14/2011 | US20110086003 Stabilization of hydrophobic protein therapeutic agents |
| 04/14/2011 | US20110083984 Substituted 2,3-dihydroimidazo[1,2-c]quinazoline Derivatives Useful for Treating Hyper-Proliferative Disorders and Diseases Associated with Angiogenesis |
| 04/14/2011 | CA2813494A1 Methods and compositions for amelioration of autoimmune disease using fusion proteins of anti-dendritic cell receptor antibody to peptide sequences |
| 04/13/2011 | EP2308880A1 Tetracyclic compound |
| 04/13/2011 | EP2308861A1 Macrocyclic compounds useful as pharmaceuticals |
| 04/13/2011 | EP2308846A2 Caspase inhibitors and uses thereof |
| 04/13/2011 | EP2308845A2 Caspase inhibitors and uses thereof |
| 04/13/2011 | EP2308844A2 Caspase inhibitors and uses thereof |
| 04/13/2011 | EP2308493A1 Ameliorating or therapeutic agent for dyslipidemia |
| 04/13/2011 | EP2307407A2 Fxa inhibitors with cyclic amidoxime or cyclic amidrazone as p4 subunit, processes for their preparations, and pharmaceutical compositions and derivatives thereof |